Over the Counter Natural Cures (29 page)

70. Marilyn Barrett.
The Handbook of Clinically Tested Herbal Remedies,
Vol. 2. Hawthorn Herbal Press. 2004.

71. Jane Higdon.
An Evidence-Based Approach to Vitamins and Minerals: Health
Benefits and Intake Recommendations,
2003.

 

Chapter 5

72. www.health.harvard.edu/press_releases/sleep_deprivation_problem.

73. R.H. Yang. “Paradoxical sleep deprivation impairs spatial learning and affects membrane excitability and mitochondrial protein in the hippocampus.”
Brain
Research.
2008; 1230: 224–232.

74. Ruben Guzmán-Marín, et al. “Sleep deprivation reduces proliferation of cells in the dentate gyrus of the hippocampus in rats.”
The Journal of Physiology.
2003; 549(2): 563–571.

75. William Lee. “Assessing causality in ALF: results from the ALF study group.” UT Southwestern Medical Center, Dallas, Texas. January 26, 2006. www8.utsouthwestern.edu/liver.

76. Stephanie Saul. “Sleep drugs found only mildly effective, but wildly popular.”
New York Times.
October 3, 2007.

77. Stephen Bent, Amy Padula, Dan Moore, Michael Patterson, and Wolf Mehling. “Valerian for sleep: a systematic review and meta-analysis.”
The American
Journal of Medicine
. 2006; 119 (12): 1005–1012.

78. www.rls.org/Page.aspx?pid=479.

79. J. Lazarou, B. Pomeranz, and P. Corey. “Incidence of adverse drug reactions in hospitalized patients.”
Journal of the American Medical Association
. 1998; 279: 1200–1205.

 

Chapter 6

80. Cesar A. Arias and Barbara E. Murray. “Antibiotic-resistant bugs in the 21st century—a clinical super-challenge.”
New England Journal of Medicine
. 2009; 360(5): 439–443.

81. Ibid.

82. Ibid.

83. Ricki Lewis. “The rise of antibiotic-resistant infections.”
FDA Consumer
Magazine
. September 1995.

84. Cesar A. Arias and Barbara E. Murray. “Antibiotic-resistant bugs in the 21st century—A clinical super-challenge.”
New England Journal of Medicine.
2009; 360(5): 439–443.

85. B.P. McCloskey. “The relation of prophylactic inoculations to the onset of poliomyelitis: a study of 620 cases in the Victorian epidemic of poliomyelitis in 1949.”
The Medical Journal of Australia.
1951; 1(17): 613–618.

86. Laura MacInnis. “Nigeria fights rare vaccine-derived polio outbreak.” Reuters. October 8, 2007.

87. Joel Arak. “Whooping cough deaths on the rise.” Reuters. July 18, 2002.

88. Alison Young. “Whooping cough vaccine not as powerful as thought.”
Atlanta
Journal-Constitution
. March 22, 2009.

89. R. Mendelsohn.
How To Raise A Healthy Child in Spite of Your Doctor
. Chicago: Contemporary Books, 1984.

90. R.M. Jacobson, G.A. Poland, R.A. Viekant, V.S. Pankratz, D.J. Schaid, S.J. Jacobsen, J.S. Sauver, and S.B. Moore. “The association of class I HLA alleles and antibody levels after a single dose of measles vaccine.”
Human Immunology
. 2003; 64(1): 103–9.

91. Gustavo H. Dayan, MD, M. Patricia Quinlisk, MD, MPH, Amy A. Parker, MSN, MPH, Albert E. Barskey, MPH, Meghan L. Harris, MPH, Jennifer M. Hill Schwartz, MPH, Kae Hunt, BA, Carol G. Finley, BS, Dennis P. Leschinsky, BS, Anne L. O'Keefe, MD, MPH, Joshua Clayton, BS, Lon K. Kightlinger, PhD, MSPH, Eden G. Dietle, BS, Jeffrey Berg, Cynthia L. Kenyon, MPH, Susan T. Goldstein, MD, Shannon K. Stokley, MPH, Susan B. Redd, Paul A. Rota, PhD, Jennifer Rota, MPH, Daoling Bi, MS, Sandra W. Roush, MT, MPH, Carolyn B. Bridges, MD, Tammy A. Santibanez, PhD, Umesh Parashar, MB, BS, MPH, William J. Bellini, PhD, and Jane F. Seward, MB, BS, MPH “Recent resurgence of mumps in the United States.”
New England Journal of Medicine
. 2008; 358(15): 1580–1589.

92. Centers for Disease Control. www.cdc.gov/mmwr/preview/mmwrhtml/mm 5301a3.htm.

93. Brenda Goodman. “Doubts grow over flu vaccine in elderly.”
New York Times
. September 1, 2008.

94. www.modernmom.com/mommywood/article/2201.

95. David Pacchioli. “The joy of garlic.”
Research/Penn State
. 1999; 20(2). www. rps.psu.edu/may99/garlic.html.

96. Eikai Kyo, Naoto Uda, Shigeo Kasuga, and Yoichi Itakura. “Immunomodulatory effects of aged garlic extract.”
Journal of Nutrition.
2001; 131: 1075S–1079S.

97. Youhong Xu, et al. “An investigation on the antimicrobial activity of Andrographis paniculata extracts and Andrographolide in vitro.”
Asian Journal
of Plant Sciences
. 2006; 5(3): 527–530.

 

Chapter 7

98. Prostate Enlargement: Benign Prostatic Hyperplasia, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, 1991; Current Estimates from the National Health Interview Survey, 1994; National Center for Health Statistics, Centers for Disease Control and Prevention (CDC), U.S. Deptartment of Health and Human Services (HHS), December 1995.

99. Ibid.

100. D. Bach and L. Ebling. “Long-term drug treatment of benign prostatic hyperplasia: results of a prospective three-year multicenter study using sabal extract IDS 89.”
Phytomedicine
. 1996; 3: 105–111.

101. M. Suzuki, Y. Ito, T. Fujino, M. Abe, K. Umegaki, S. Onoue, H. Noguchi, and S. Yamada. “Pharmacological effects of saw palmetto extract in the lower urinary tract.”
Acta Pharmacologica Sinica
. 2009; 30(3): 227–81.

102. Frans Debruyne, Peter Boyle, Fernando Calais, Da Silva, Jay G. Gillenwater, Freddie C. Hamdy, Paul Perrin, Pierre Teillac, Remigio Vela-Navarrete, Jean-Pierre Raynaud, and Claude C. Schulman. “Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients—PERMAL study subset analysis.”
European Urology
. 2004; 45(6): 773–780.

103. A.B. Awad, A.T. Burr, and C.S. Fink. “Effect of resveratrol and beta-sitosterol in combination on reactive oxygen species and prostaglandin release by PC-3 cells.”
Prostaglandins Leukotrienes and Essential Fatty Acids
. 2005; 72(3): 219–26.

104. R.R. Berges, J. Windeler, and H.J. Trampisch, et al. “Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia.”
Lancet
. 1995; 345: 152932.

105. M.C. Andro and J.P. Riffaud. “
Pygeum africanum
extract for the treatment of patients with benign prostatic hyperplasia: a review of twenty-five years of published experience.”
Current Therapeutic Research.
1995; 56: 796–817.

106. G. Schiebel-Schlosser and M. Friederich. “Phytotherapy pf BPH with pumpkin seeds—a multicenter clinical trial.
Zeits Phytother
. 1998; 19: 71–6; M. Friederich, C. Theurer, G. Schiebel-Scholosser. “Prosta Fink Forte capsules in the treatment of benign prostatic hyperplasia.” (Multicentric surveillance study in 2245 patients.)
Forsch Komplementarmed Klass Naturheilkd
. 2000; 7: 200–4 [in German]; Zhang X, Ouyang JZ, Zhang YS, et al. “Effect of the extracts of pumpkin seeds on the urodynamics of rabbits: an experimental study.”
Journal of Tongji Medical University.
1994; 14: 235–8.

 

Chapter 8

107. Vision Problems in the U.S. Report (Prevent Blindness America and NEI).
Archives of Ophthalmology
. 2004; 122: 532–538, 564–572. www.usvisionproblems.org and www.nei.nih.gov.

108. F.J. Giblin. “Glutathione: a vital lens antioxidant.”
Journal of Ocular
Pharmacology and Therapeutics
. 2000; 16(2): 121–35.
C.R. Gale, N.F. Hall, D.I. Phillips, et al. “Plasma antioxidant vitamins and carotenoids and age-related cataract.”
Ophthalmology
, 2001; 108: 1992–1998. P.F. Jacques, L.T. Chylack, Jr., S.E. Hankinson, et al. “Long-term nutrient intake and early age-related nuclear lens opacities,”
Archives of Ophthalmology
. 2001; 119: 1009–1019. (In one study, a combination of bilberry and vitamin E stopped cataract formation in 97 percent of the patients without side effects.) G.O. Bravetti. “Preventive medical treatment of senile cataract with vitamin E and
Vaccinium myrtillus
anthocyanosides.” Clinical evaluation.
Ann Ottalmol
Clinical Ocul
. 115 (1989): 109.
A. Taylor. “Cataract: relationship between nutrition and oxidation.”
Journal of
the American College of Nutrition
. 1993; 12(2): 138–46.
M.C. Leske, L.T. Chylack Jr., Q. He, S.Y. Wu, E. Schoenfeld, J. Friend, and J. Wolfe. “Antioxidant vitamins and nuclear opacities: the longitudinal study of cataract.” University Medical Center at Stony Brook, New York. 1998; 105(5): 831–836. (OBJECTIVE: The association of antioxidant nutrients and risk of nuclear opacification was evaluated in the Longitudinal Study of Cataract;
Antioxidants May Slow Cataract Progression; A nutritional diet that includes beta-carotene [18 mg/day], vitamin C [750 mg/day], and vitamin E [600 mg/ day] has been shown to modify the progression of cataracts, according to the Roche European-American Cataract Trial results; Dietary lutein and cryptoxanthin were associated with 70 percent lower risk of nuclear cataracts in those under age sixty-five.)

109. M.S. Passo, et al. “Regular exercise lowers intraocular pressure in glaucoma patients.”
Investigative Ophthalmology
.
ARVO Abstracts
. 1994; 35.

 

Chapter 9

110. “War on cancer needs ‘new direction,' panel tells congress.”
New York Times
. September 30, 1994; “Cancer passes heart disease as top killer.” Associated Press. January 20, 2005.

111. C.M. Leontine Kremer, MD, PhD and Huib N. Caron, MD, PhD. “Anthracycline cardiotoxicity in children.”
New England Journal of Medicine
. 2004; 351(2): 120–121.

112. Featured on NBC News
Today Show
. www.medpagetoday.com/Meeting Coverage/SABCS/7682.

113. National Cancer Institute Fact Sheet. www.cancer.gov/cancertopics/factsheet/therapy/tamoxifen.

114. Report on Carcinogens, Eleventh Edition. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program.

115. C.M. Leontine Kremer, MD, PhD, and Huib N. Caron, MD, PhD. “Anthracycline cardiotoxicity in children.”
New England Journal of Medicine
. 2004; 351(2): 120–121.

116. Ellis Rehema. “Cancer docs profit from chemotherapy drugs.” NBC. September 21, 2006; Maartje J. Hooning, PhD, department of medical oncology, Erasmus Medical Center, Daniel den Hoed Cancer Center, Rotterdam, the Netherlands; Jay Brooks, MD, chairman, hematology/oncology, Ochsner Health System, Baton Rouge, Louisiana;
Journal of Clinical Oncology
.

117. Amanda Gardner. “Younger breast cancer survivors risk disease in other breast.”
Washington Post
. October 15, 2008.

118. Jon Christensen. “Scientist at work: John Reed; running hot in pursuit of cancer treatment.”
New York Times
. December 12, 2005.

119. John C. Reed, MD, PhD. Research Focus Burnham Institute of Medical Research. www.burnham.org/default.asp?contentID=215.

120. Annelyse Duvois, et al. “Chemopreventive and therapeutic effects of curcumin.”
Cancer Letters.
2005; 223: 181–190.

121. Bryan Smith. “Indian gold.”
Men's Health.
2008.

122. Bryan Smith. “Best food for men nutrition awards.”
Men's Health
. 2008.

123. Jeremy James Johnson and Hasan Mukhtar. “Curcumin for chemoprevention of colon cancer.”
Cancer Letters
. 2007; 255(2): 170–181.

124. K.M. Dhandapani, V.B. Mahesh, and D.W. Brann. “Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.”
Journal of Neurochemistry
. 2007; 102(2): 522–38.

125. Matthew Miller, Shenglin Chen, Jeffrey Woodliff, and Sanjay Kansra. “Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.”
Endocrinololgy.
2008; 149 (8): 4158–67.

126. “Sunshine might stop skin cancers,” BBC News, February 1, 2005. http://news. bbc.co.uk/2/hi/health/4225195.stm.

127. Lawrence H. Kushi, ScD, Tim Byers, MD, MPH, Colleen Doyle, MS, RD, Elisa V. Bandera, MD, PhD, Marji McCullough, ScD, RD, Ted Gansler, MD, MBA, Kimberly S. Andrews, Michael J. Thun, MD, MS, and The American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee. “American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention.”
A Cancer Journal for Clinicians
. 2006; 56: 254–281.

128. C. Garland, F. Garland, and E. Gorham. “Could sunscreens increase melanoma risk?”
American Journal of Public Health
82 1992; (4): 614–5.

 

Chapter 10

129. Pope Parker. “Diabetes: underrated, insidious, and deadly.”
New York Times.
July 1, 2008.

130. H.M. Connolly, J.L. Crary, and M.D. McGoon, et al. “Valvular heart disease associated with fenfluramine-phentermine.”
New England Journal of Medicine.
1997; 337: 581–588.

131. Gadde et al,"Bupropion for weight loss: an investigation of efficacy and tolerability
in overweight and obese women.”
Obesity Research
. 2001; 9(9): 544–551.

132. K. Venkat Narayan. “Lifetime risk for diabetes mellitus in the United States.”
Journal of the American Medical Association
. 2003; 290: 1884–1890.

133. http://public.nhlbi.nih.gov/newsroom/home/GetPressRelease.aspx?id =2573

134. Alam Khan, et al. “Cinnamon improves glucose and lipids of people with type 2 diabetes.”
Diabetes Care
. 2003; 26: 3215–3218.

135. Joanna Hlebowicz, et al. “Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects.”
American Journal of Clinical
Nutrition
. 2007; 85(6): 1552-1556.